{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T01:36:50Z","timestamp":1750383410671,"version":"3.38.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.esmoop.2024.104001","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T06:32:16Z","timestamp":1736058736000},"page":"104001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI)"],"prefix":"10.1016","volume":"10","author":[{"given":"M.","family":"Reni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Milella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bergamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Di Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Giommoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.G.","family":"Cardellino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Cavanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bonomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Zustovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bozzarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Salmaso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Spada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Orsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Macchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Insolda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Procaccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Santoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Caldirola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.esmoop.2024.104001_bib1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review","volume":"326","author":"Park","year":"2021","journal-title":"J\u00a0Am Med Assoc"},{"issue":"11","key":"10.1016\/j.esmoop.2024.104001_bib2","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1093\/annonc\/mdx495","article-title":"Selecting patients for resection after primary chemotherapy for non-metastatic pancreatic adenocarcinoma","volume":"28","author":"Reni","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.esmoop.2024.104001_bib3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s11912-013-0366-9","article-title":"Resectable, borderline resectable, and locally advanced pancreatic cancer: what does it matter?","volume":"16","author":"Halperin","year":"2014","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.esmoop.2024.104001_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/bjs.5982","article-title":"Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy","volume":"95","author":"Balzano","year":"2008","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.esmoop.2024.104001_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100777","article-title":"Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey","volume":"8","author":"Reni","year":"2023","journal-title":"ESMO Open"},{"issue":"4","key":"10.1016\/j.esmoop.2024.104001_bib6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ijrobp.2017.11.040","article-title":"The impact of academic facility type and case volume on survival in patients undergoing curative radiation therapy for muscle-invasive bladder cancer","volume":"100","author":"Bajaj","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.esmoop.2024.104001_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.surg.2020.05.023","article-title":"Are academic hospitals better at treating metastatic colorectal cancer?","volume":"169","author":"Atallah","year":"2021","journal-title":"Surgery"},{"key":"10.1016\/j.esmoop.2024.104001_bib8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.suronc.2019.10.009","article-title":"Hepatocellular carcinoma: impact of academic setting and hospital volume on patient survival","volume":"31","author":"Uhlig","year":"2019","journal-title":"Surg Oncol"},{"key":"10.1016\/j.esmoop.2024.104001_bib9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.urology.2021.09.009","article-title":"Association between surgical volume and survival among patients with variant histologies of bladder cancer","volume":"159","author":"Sui","year":"2022","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.esmoop.2024.104001_bib10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijrobp.2018.05.038","article-title":"Outcomes for cervical cancer patients treated with radiation in high-volume and\u00a0low-volume hospitals","volume":"102","author":"Lin","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.esmoop.2024.104001_bib11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/COC.0000000000000582","article-title":"The impact of radiotherapy facility volume on the survival and guideline concordance of patients with muscle-invasive bladder cancer receiving bladder-preservation therapy","volume":"42","author":"D\u2019Rummo","year":"2019","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2024.104001_bib12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ygyno.2015.07.015","article-title":"Influence of treatment center and hospital volume on survival for locally advanced cervical cancer","volume":"139","author":"Wright","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2024.104001_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zrac140","article-title":"The impact of hospital volume on survival in patients with locally advanced colonic cancer","volume":"6","author":"Rosander","year":"2022","journal-title":"BJS Open"},{"issue":"3","key":"10.1016\/j.esmoop.2024.104001_bib14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11060-017-2598-2","article-title":"Association between hospital volume and receipt of treatment and survival in patients with glioblastoma","volume":"135","author":"Koshy","year":"2017","journal-title":"J\u00a0Neurooncol"},{"issue":"1","key":"10.1016\/j.esmoop.2024.104001_bib15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12885-021-07868-8","article-title":"Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patients","volume":"21","author":"Baeg","year":"2021","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.esmoop.2024.104001_bib16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/CORR.0000000000001034","article-title":"Is treatment at a high-volume center associated with an improved survival for primary malignant bone tumors?","volume":"478","author":"Malik","year":"2020","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"10.1016\/j.esmoop.2024.104001_bib17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/0284186X.2021.2012252","article-title":"Disparity in use of modern combination chemotherapy associated with facility type influences survival of 2655 patients with advanced pancreatic cancer","volume":"61","author":"Ladekarl","year":"2022","journal-title":"Acta Oncol"},{"key":"10.1016\/j.esmoop.2024.104001_bib18","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jamaoncol.2022.3829","article-title":"Five-year outcomes of FOLFIRINOX vs gemcitabine as adjuvant therapy for pancreatic cancer: a randomized clinical trial","volume":"8","author":"Conroy","year":"2022","journal-title":"JAMA Oncol"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S205970292401771X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S205970292401771X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T10:12:01Z","timestamp":1740651121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S205970292401771X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S205970292401771X"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2024.104001","relation":{},"ISSN":["2059-7029"],"issn-type":[{"type":"print","value":"2059-7029"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI)","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2024.104001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"104001"}}